#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Interstitial lung disease Hereditary neuropathic amyloidosis Guillain-Barre syndrome Congenital pseudarthrosis Sexually transmitted disease Oesophageal carcinoma Cutaneous T-cell lymphoma refractory Pouchitis Hepatic angiosarcoma T-cell lymphoma Hodgkin's disease refractory Hypergammaglobulinaemia benign monoclonal Mitochondrial myopathy Hydrocephalus Hyperphagia More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis – Life with Disease Soft tissue sarcoma – Trials in Disease Glycogen storage disease type V – Diagnostics Haemophilia A without inhibitors Myelodysplastic syndrome – Life with Disease Mantle cell lymphoma refractory – Life with Disease Activated PI3 kinase delta syndrome – Diagnostics Pemphigoid – Basic Information Antithrombin III deficiency – Basic Information Alternating hemiplegia of childhood – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Loncastuximab Tesirine 99MTC-EUK-(SO3)CY5-MAS3 Ammonium Chloride Nirogacestat Hydrobromide Ranibizumab Vibosameran Dopamine Hydrochloride AUROCELL-TX Eplerenone Dextromethorphan Hydrobromide Pritelivir OLVEREMBATINIB Benzyl Alcohol Botensilimab Lauromacrogol 400 Mk-6194 Micafungin Litifilimab Sodium Fluoride (18F) Piracetam More therapies…

    Learn about Your Condition

    Univentricular heart Psychotic disorder Prostate cancer metastatic Hyperphagia Deep vein thrombosis Papillary thyroid cancer Cough Alexander disease Penile squamous cell carcinoma Lung adenocarcinoma stage III Otitis media Device related infection Rheumatic disorder Deafness bilateral Hepatocellular carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • A study of daraxonrasib (RMC-6236) compared to observation in patients with resected pancreatic cancer following chemotherapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    Investigated Drugs:
    • (12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE
    France Germany Italy Spain

  • Study on Long-Term Safety and Effects of Maralixibat for Patients with Alagille Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Alagille syndrome
    Investigated Drugs:
    • MARALIXIBAT
    Belgium France Germany Italy The Netherlands Portugal +1

  • Patient‑controlled propofol versus alfentanil and midazolam sedation for adenoma patients undergoing diagnostic and therapeutic colonoscopy: a satisfaction study

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Midazolam
    • Propofol
    Sweden

  • Immune Modulation Study of Rilvegostomig and Pembrolizumab in Patients with Advanced Gastric Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Rilvegostomig
    • Pembrolizumab
    Spain

  • Study of REC-4881 in Adults with Familial Adenomatous Polyposis to Assess Safety and Efficacy

    Not yet recruiting

    2 1
    Germany The Netherlands Spain

  • Patient‑controlled remimazolam, alfentanil and midazolam sedation for outpatients undergoing colonoscopy: safety, efficacy and satisfaction study

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Midazolam
    • Remimazolam
    Denmark
Previous Page
1 … 44 45 46 47 48 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!